Helix BioPharma Corp. (TSE:HBP – Get Free Report) shares passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$0.93 and traded as high as C$0.98. Helix BioPharma shares last traded at C$0.98, with a volume of 2,551 shares trading hands.
Helix BioPharma Price Performance
The company has a market capitalization of C$51.96 million, a P/E ratio of -1.03 and a beta of -0.84. The firm has a 50-day moving average price of C$0.93 and a two-hundred day moving average price of C$0.99.
Helix BioPharma Company Profile
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
Further Reading
- Five stocks we like better than Helix BioPharma
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Chaos and Cash: Finding Opportunity in Volatility
- Stock Market Upgrades: What Are They?
- Realty Income: An Anchor in Volatile Markets
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Receive News & Ratings for Helix BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
